Differential approach to treating life-threatening arrhythmogenic conditions in patients with X-linked Emery—Dreifuss myopathy
Abstract
The paper gives 2 clinical examples of patients with the same diagnosis of progressive X-linked Emery-Dreifuss muscular dystrophy and the different course of rhythm and conduction disorders, which have determined various approaches to management tactics. There is evidence for a differential approach to pacemaker implantation, by confirming the correctness of management tactics in a long-term follow-up. A 27-year-old patient had no indications for pacemaker implantation. The other patient aged 13 years was found to have indications and underwent implantation; however, thrombi formed on the electrodes and the atrial electrode needed to be further disconnected.
About the Authors
O. S. GroznovaRussian Federation
G. E. Rudenskaya
Russian Federation
T. A. Adyan
Russian Federation
D. A. Kharlamov
Russian Federation
References
1. Finsterer J., Stollberger С. Primary myopathies and the heart. Scand Cardiovasc J 2008; 42; 1: 9-24.
2. Raffaele di Barletta M., Ricci E., Galluzzi G. et al. Different mutations in the LMNA gene cause autosomal dominant and autosomal recessive Emery—Dreifuss muscular dystrophy. Am J Hum Genet 2000; 66: 1407-1412.
3. Manilal S., Recan D., Sewry С A. et al. Mutations in Emery-Dreifuss muscular dystrophy and their effectes on emerin protein expression. Hum Mol Genet 1998; 7: 855-864.
4. Puckelwartz, M., McNally EM. Emery—Dreifuss muscular
5. dystrophy. Handb ClinNeurol2011; 101: 155-166.
6. Hermans M. C, Pinto Y.M., Merkies I.S. et al. Hereditary muscular dystrophies and the heart. Neuromuscul Disord 2010; 20: 8: 479-492.
7. Parmar M.S., Parmar K.S. Emery—Dreifuss humeroperoneal muscular dystrophy: cardiac manifestations. Can J Cardiol 2012; 28: 4: 516.
8. Wessely R., Seidl S., Schomig A. Cardiac involvement in Emery—Dreifuss muscular dystrophy. Clin Genet 2005; 67: 220-223.
9. Ishikawa К, Mimuro М., Тапака Т. Ventricular arrhythmia in X-linked Emery-Dreifuss muscular dystrophy: a lesson from an autopsy case. Intern Med 2011; 50: 5: 459—462.
10. Van Berlo J.H., De Voogt W.G., Van derKooiAJ. et al. Meta-analysis of clinical characteristics of 299 carriers of LMNA gene mutations: do lamin A/C mutations portend a high risk of sudden death? J Mol Med (Berl) 2005; 83: 1: 79-83.
11. Nigro G., Russo V, Ventriglia V.M. et al. Early onset of cardio-myopathy and primary prevention of sudden death in X-linked Emery—Dreifuss muscular dystrophy. Neuromuscul Disord 2010; 20: 3: 174-177.
12. Zaim S., Bach J., Michaels J. Sudden death in an Emery—
13. Dreifuss muscular dystrophy patient with an implantable defi-brfflator. Am J Phys Med Rehabil 2008; 87: 4: 325-329.
14. Golzio P.G., ChiribiriA., Gaita F. 'Unexpected' sudden death avoided by implantable cardioverter defibrfflator in Emery Dreifuss patient. Europace 2007; 9: 12: 1158-1160.
15. Грознова О.С, Новиков П.В. Ранняя диагностика поражения сердца при Х-сцепленной форме мышечной дистрофии Эмери—Дрейфуса у детей. Рос вестн перинатол и педиат 2011; 1; 27-32. (Groznova O.S., Novikov P.V. Early diagnosis of cardiac lesion in X-linked Emery-Dreifus muscular dystrophy in children. Ros vestn perinatol i pediat 2011; 1; 27-32.)
Review
For citations:
Groznova O.S., Rudenskaya G.E., Adyan T.A., Kharlamov D.A. Differential approach to treating life-threatening arrhythmogenic conditions in patients with X-linked Emery—Dreifuss myopathy. Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics). 2015;60(4):63-68. (In Russ.)